SHSE •
Healthcare •
Biotechnology •
Quote as of 07/29/2026 15:00
Company Profile
IndustryBiotechnology
SectorHealthcare
ExchangeSHSE
Market Capitalization16,147 mln
Float179 mln
Relative Strength
1
/ 100
Severely lagging
Debt / Equity
0.00
Debt-free
ROE
-18.19
Negative
Dividend Yield
0.00%
No dividend
DPS
0.00
No dividend
Payout Ratio
0%
No payout
Business Description
BeBetter Med Inc. is a Guangzhou-based drug company founded in 2012 that focuses on developing and selling treatments for cancer, autoimmune conditions, and metabolic disorders. The company has built a broad pipeline of experimental therapies targeting a wide range of disease mechanisms, spanning small molecule drugs to nucleic acid-based treatments. Its work spans early research through to commercial sales across all three disease areas.
